General Information of the Compound
| Compound ID |
CP0471921
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-[4-[[(4aR,10bR)-4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-yl]oxy]butoxy]-3,4-dihydro-1H-quinolin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H34N2O5
|
||||||||||||||||||
| Molecular Weight |
466.578
|
||||||||||||||||||
| Canonical SMILES |
CCCN1CCO[C@H]2[C@H]1COc1ccc(OCCCCOc3ccc4CCC(=O)Nc4c3)cc21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H34N2O5/c1-2-11-29-12-15-33-27-22-16-20(8-9-25(22)34-18-24(27)29)31-13-3-4-14-32-21-7-5-19-6-10-26(30)28-23(19)17-21/h5,7-9,16-17,24,27H,2-4,6,10-15,18H2,1H3,(H,28,30)/t24-,27-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CCLFPDYNKMPZJO-SHQCIBLASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor